InvestorsHub Logo
Followers 10
Posts 1249
Boards Moderated 0
Alias Born 07/20/2020

Re: None

Wednesday, 08/03/2022 10:35:16 AM

Wednesday, August 03, 2022 10:35:16 AM

Post# of 640596
(APTX) $0.47 --Cash $1.48 per shr --important data readout in the coming days

Aptinyx continues to believe that NYX-2925 can offer a novel therapeutic approach for fibromyalgia. To this end, the company plans to report data from ongoing fibromyalgia phase 2b study in early to mid third quarter.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.